Margarita Silva-Hutner: Difference between revisions
MurielMary (talk | contribs) |
MurielMary (talk | contribs) →Legacy: this is usual academic work, not notable |
||
Line 9: | Line 9: | ||
== Legacy == |
== Legacy == |
||
Silva-Hutner was a founding member of the Medical Mycological Society of New York<ref name=":2" />. Her research contributed to the development of Nystatin, the first antifungal medicine approved for human use |
Silva-Hutner was a founding member of the Medical Mycological Society of New York<ref name=":2" />. Her research contributed to the development of Nystatin, the first antifungal medicine approved for human use<ref name=":2" />. She served as Chair of the Nomination Committee for the Medical Mycological Society of the Americas at the time of its founding and was active within the organization<ref>{{Cite web|title=History|url=https://www.mycologicalsociety.org/history|access-date=2020-10-24|website=Medical Mycological Society of the Americas}}</ref>. |
||
Silva-Hutner’s work on chromoblastomycosis laid the groundwork for further research on this pathogen, which remains among the most difficult fungal infections to manage<ref>{{Cite journal|last=Krzyściak|first=Paweł M.|last2=Pindycka-Piaszczyńska|first2=Małgorzata|last3=Piaszczyński|first3=Michał|date=October 2014|title=Chromoblastomycosis|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221348/|journal=Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii|volume=31|issue=5|pages=310–321|doi=10.5114/pdia.2014.40949|issn=1642-395X|pmc=4221348|pmid=25395928}}</ref>. She published more than fifty articles on the biology and taxonomy of pathogenic fungi over the course of her career<ref name=":1" />. According to SemanticScholar.org, Silva-Hutner has 289 citations under her maiden name of M. Silva<ref>{{Cite web|title=M. Silva {{!}} Semantic Scholar|url=https://www.semanticscholar.org/author/M.-Silva/145496489|access-date=2020-10-24|website=www.semanticscholar.org|language=en}}</ref> and 214 citations under M. Silva-Hutner<ref>{{Cite web|title=Margarita Silva-Hutner {{!}} Semantic Scholar|url=https://www.semanticscholar.org/author/Margarita-Silva-Hutner/1412540175|access-date=2020-10-24|website=www.semanticscholar.org|language=en}}</ref>. This illustrates the extent of her contributions to the field of mycology. |
Silva-Hutner’s work on chromoblastomycosis laid the groundwork for further research on this pathogen, which remains among the most difficult fungal infections to manage<ref>{{Cite journal|last=Krzyściak|first=Paweł M.|last2=Pindycka-Piaszczyńska|first2=Małgorzata|last3=Piaszczyński|first3=Michał|date=October 2014|title=Chromoblastomycosis|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221348/|journal=Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii|volume=31|issue=5|pages=310–321|doi=10.5114/pdia.2014.40949|issn=1642-395X|pmc=4221348|pmid=25395928}}</ref>. She published more than fifty articles on the biology and taxonomy of pathogenic fungi over the course of her career<ref name=":1" />. According to SemanticScholar.org, Silva-Hutner has 289 citations under her maiden name of M. Silva<ref>{{Cite web|title=M. Silva {{!}} Semantic Scholar|url=https://www.semanticscholar.org/author/M.-Silva/145496489|access-date=2020-10-24|website=www.semanticscholar.org|language=en}}</ref> and 214 citations under M. Silva-Hutner<ref>{{Cite web|title=Margarita Silva-Hutner {{!}} Semantic Scholar|url=https://www.semanticscholar.org/author/Margarita-Silva-Hutner/1412540175|access-date=2020-10-24|website=www.semanticscholar.org|language=en}}</ref>. This illustrates the extent of her contributions to the field of mycology. |
Revision as of 08:45, 26 October 2020
This article, Margarita Silva-Hutner, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Dr. Margarita Silver-Hutner (28 November 1915 - 6 February 2002)[1] was a prominent mycologist. Known as the “Matriarch of Medical Mycology”[2], Silva-Hutner’s work at Columbia University as a researcher and instructor was highly influential to the field of medical mycology and mycology as a whole.
Life & Career
Silva-Hutner was born November 28, 1915, in Rio Piedras, Puerto Rico[1]. She graduated with a B.A. from the University of Puerto Rico in 1936[1]. She then worked at the Columbia University School of Tropical Medicine in San Juan under Arturo L. Carrión, MD for 13 years[2]. Silva-Hunter’s work with Carrión focused on fungal infections, especially chromoblastomycosis[2]. Medical mycology was a young field at the time, with the first laboratory focused on this area in the United States opening in 1926[2]. Her work was foundational to this rapidly expanding area of research.
Silva-Hutner began attending Harvard on scholarship in 1950 and joined the Mycology Laboratory at Columbia-Presbyterian Medical Center later that year[2]. She received her doctorate in 1952[1]. In 1956, Silva-Hutner became Director of the Mycology Laboratory and an Assistant Professor in the College of Physicians & Surgeons[1]. That same year she married Seymour H. Hutner[1]. She was promoted to Associate Professor in 1963[1] and remained on the faculty at Columbia University for over fifty years[3]. She retired from her position as Director in 1981 but continued to teach as a Special Lecturer[1]. Silva-Hutner died on February 6, 2002 after a lengthy illness[1].
Legacy
Silva-Hutner was a founding member of the Medical Mycological Society of New York[3]. Her research contributed to the development of Nystatin, the first antifungal medicine approved for human use[3]. She served as Chair of the Nomination Committee for the Medical Mycological Society of the Americas at the time of its founding and was active within the organization[4].
Silva-Hutner’s work on chromoblastomycosis laid the groundwork for further research on this pathogen, which remains among the most difficult fungal infections to manage[5]. She published more than fifty articles on the biology and taxonomy of pathogenic fungi over the course of her career[2]. According to SemanticScholar.org, Silva-Hutner has 289 citations under her maiden name of M. Silva[6] and 214 citations under M. Silva-Hutner[7]. This illustrates the extent of her contributions to the field of mycology.
Honors and Awards
In 1986 she was the recipient of the Medical Mycological Society of the America’s Rhonda Benham Award.[8] In 1996, she was given an award for “Excellence in Medical Mycology” at a symposium called “A Diagnostic Medley of Medical Mycology.”[9] Silva-Hutner was also a Fellow and Diplomate of the American Board of Medical Microbiology[9].
References
- ^ a b c d e f g h i "Margarita Silva-Hutner Medical Mycology Laboratory collection | Archives and Special Collections". www.library-archives.cumc.columbia.edu. Retrieved 2020-10-24.
- ^ a b c d e f cmm_admin (2016-05-29). "Women—Long Denied a Role at P&S—Helped Shape Medicine in the 20th Century". Columbia Medicine Magazine. Retrieved 2020-10-24.
- ^ a b c "Margarita Hutner - Obituary". www.legacy.com. Retrieved 2020-10-24.
- ^ "History". Medical Mycological Society of the Americas. Retrieved 2020-10-24.
- ^ Krzyściak, Paweł M.; Pindycka-Piaszczyńska, Małgorzata; Piaszczyński, Michał (October 2014). "Chromoblastomycosis". Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii. 31 (5): 310–321. doi:10.5114/pdia.2014.40949. ISSN 1642-395X. PMC 4221348. PMID 25395928.
- ^ "M. Silva | Semantic Scholar". www.semanticscholar.org. Retrieved 2020-10-24.
- ^ "Margarita Silva-Hutner | Semantic Scholar". www.semanticscholar.org. Retrieved 2020-10-24.
- ^ "Rhoda Benham Awardees". Medical Mycological Society of the Americas. Retrieved 2020-10-24.
- ^ a b Espinel-Ingroff, A.; Weitzman, I. (2004). "Obituary: Margarita Silva-Hutner". Mycopathologia. doi:10.1023/A:1016002215210.
Category:Women in science and technology Category:Mycologists
This article, Margarita Silva-Hutner, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |